Wim, Exactly. That is why I am more optimistic now that I have been for a while. Think about it. what has our problem been ? NOT the drugs, but the man running the show. With one more dilution he needs to sell off 25% of the company to get maybe 5 million dollars. Assuming Boyd gets that, it gives him access to 45% of the company! That is more than enough to force changes.
So what are our choices? hold or sell? for me why sell now at all time lows. I can hold because worse case scenario things can change around rather quickly.
They way I see it, if he dilutes for 5 million we are good for almost year end. Boyd could come in and immediately start changes. 1st thing sell off generics for say 15 million. they could get more but if you want to move them sell them all for cheap. That gives enough cash through next year.
Next step as soon as Rexista studies are done, partner it. that could be by October and would probably come with up front payment because it is almost done. even a mere 10 million gets us through 2019 now along with sale of generics.
Next Partner Regabatin with no upfront payment but milestones. the first tests would take a while but I am sure would be done by the end of 2019. then you get the milestone payments.
by this time Rexista is approved in 2018 and should be on market by year end.
Nothing stops a plan from this from happening except one person! with a change that is about to come, that person no longer stands in the way. The drugs are still good. the biggest obstacle to our success is about to be removed. so I for one am not displeased. so after the all the hurt that he has put us longs through our only choice is to cost avg down at these historic lows. or just hold and then wait for share price recovery. I guess you could sell and take the loss but for as far down as we are you better have a great investment to get it back. I still see this recovering to quickly that even getting back up to $1 pre split price isn't bad if you cost avg down now! thats how I look at it.
